av/arcadia-biosciences--big.svg

NASDAQ:RKDA

Arcadia Biosciences, Inc.

  • Stock

USD

Last Close

2.08

10/05 20:00

Market Cap

2.82M

Beta: 0.96

Volume Today

13.44K

Avg: 172.60K

PE Ratio

−0.33

PFCF: −0.20

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
674K
-
437K
35.16%
359K
17.85%
273K
23.96%
240.50K
11.90%
205K
14.76%
987.50K
381.71%
2.80M
183.85%
4.12M
47.07%
3.50M
15.05%
2.26M
35.34%
average payables
178.50K
-
232K
29.97%
1.33M
474.78%
1.32M
0.82%
294K
77.77%
1.51M
412.07%
1.57M
4.18%
2.30M
46.54%
3.87M
68.44%
3.26M
15.81%
1.84M
43.52%
average receivables
1.13M
-
1.22M
8.28%
1.10M
9.65%
660.50K
40.23%
884K
33.84%
701.50K
20.64%
385K
45.12%
1.00M
160.78%
1.39M
38.25%
1.33M
4.29%
900.50K
32.22%
book value per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
48.44
64.41%
111.36
129.91%
58.44
47.52%
35.09
39.96%
10.38
70.42%
capex per share
-2.44
-
-3.62
48.00%
-4.23
16.89%
-4.17
1.53%
-1.47
64.82%
-2.66
81.17%
-9.28
249.70%
-9.38
1.01%
-1.89
79.82%
-0.12
93.65%
-0.00
96.63%
capex to depreciation
-0.26
-
-0.41
61.64%
-0.51
24.24%
-0.76
47.95%
-0.28
62.74%
-1.62
473.32%
-7.61
368.99%
-3.53
53.67%
-0.96
72.68%
-0.15
84.40%
-0.01
96.62%
capex to operating cash flow
0.01
-
0.01
2.46%
0.01
0.15%
0.01
35.52%
0.01
58.23%
0.02
224.21%
0.09
368.26%
0.08
10.03%
0.04
49.62%
0.01
86.77%
0.00
93.65%
capex to revenue
-0.02
-
-0.02
37.32%
-0.03
31.58%
-0.07
159.80%
-0.02
72.92%
-0.17
770.25%
-1.26
639.89%
-0.29
77.00%
-0.15
48.90%
-0.01
95.13%
-0.00
87.03%
cash per share
69.32
-
405.16
484.51%
1.41K
247.38%
911.68
35.22%
241.59
73.50%
231.77
4.07%
159.24
31.29%
103.09
35.26%
53.92
47.70%
34.44
36.12%
9.41
72.67%
days of inventory on hand
244.06
-
77.50
68.25%
120.30
55.24%
102.77
14.57%
295.35
187.39%
99.95
66.16%
739.90
640.29%
267.62
63.83%
185.81
30.57%
95.74
48.48%
216.57
126.21%
days payables outstanding
119.32
-
44.60
62.62%
991.47
2,123.19%
90.54
90.87%
472.05
421.39%
1.46K
209.41%
202.92
86.11%
288.19
42.03%
152.49
47.09%
107.28
29.65%
88.60
17.42%
days sales outstanding
57.70
-
74.34
28.84%
53.13
28.54%
61.02
14.87%
111.97
83.48%
41.89
62.59%
187.96
348.76%
63.88
66.02%
73.75
15.46%
47.18
36.03%
35.20
25.40%
debt to assets
1.53
-
0.58
61.90%
0.31
46.89%
0.44
43.80%
0.00
-
0.07
5,594.17%
0.20
187.36%
0.08
62.03%
0.07
7.02%
0.05
26.72%
debt to equity
-0.84
-
-7.68
812.01%
0.57
107.42%
1.13
98.56%
0.00
-
0.29
12,741.10%
0.34
16.08%
0.11
68.59%
0.10
9.48%
0.08
18.22%
dividend yield
0.00
-
earnings yield
-0.06
-
-0.08
38.98%
-0.21
169.38%
-0.48
132.46%
-1.32
175.48%
-1.13
14.76%
-0.83
26.66%
-0.24
71.12%
-0.73
204.81%
-2.40
229.61%
-3.61
50.29%
enterprise value
250.59M
-
236.76M
5.52%
87.77M
62.93%
63.93M
27.16%
2.73M
95.72%
-58.51K
102.14%
28.69M
49,135.55%
20.51M
28.53%
-3.26M
115.89%
-12.13M
272.17%
-1.64M
86.48%
enterprise value over ebitda
-24.64
-
-16.00
35.05%
-5.95
62.81%
-3.56
40.24%
-0.20
94.41%
0.00
101.29%
-1.40
55,011.46%
-0.98
29.89%
0.18
118.02%
0.53
200.82%
0.13
76.16%
ev to operating cash flow
-25.71
-
-16.01
37.73%
-5.81
63.72%
-3.75
35.48%
-0.20
94.78%
0.00
102.19%
-1.67
38,965.19%
-0.68
59.32%
0.13
118.57%
0.87
588.80%
0.11
87.65%
ev to sales
38.68
-
33.91
12.34%
16.21
52.19%
20.05
23.69%
0.68
96.61%
-0.04
105.89%
24.54
61,509.78%
2.55
89.60%
-0.48
118.83%
-1.22
153.45%
-0.31
74.75%
free cash flow per share
-240.71
-
-365.16
51.70%
-427.47
17.07%
-311.70
27.08%
-260.53
16.41%
-147.42
43.42%
-117.40
20.37%
-130.75
11.37%
-50.52
61.36%
-23.44
53.60%
-12.37
47.23%
free cash flow yield
-0.04
-
-0.06
51.70%
-0.18
181.11%
-0.42
140.94%
-1.18
179.63%
-1.16
1.83%
-0.54
53.93%
-1.29
141.24%
-1.21
6.01%
-2.16
78.06%
-3.95
82.75%
graham net net
-562.62
-
-218.20
61.22%
475.21
317.78%
301.30
36.60%
102.05
66.13%
115.02
12.72%
15.29
86.71%
39.49
158.24%
36.10
8.57%
24.81
31.27%
4.85
80.44%
graham number
1.75K
-
681.89
61.08%
3.57K
423.71%
1.79K
50.01%
986.83
44.72%
662.11
32.91%
444.75
32.83%
246.26
44.63%
199.70
18.91%
143.40
28.19%
51.38
64.17%
income quality
0.74
-
0.81
9.18%
0.84
4.36%
0.87
3.29%
0.89
2.30%
1.01
13.73%
0.60
41.10%
5.01
741.88%
1.60
68.03%
0.90
44.16%
1.16
29.81%
intangibles to total assets
0
-
0
0
0
0
0
0
0.02
Infinity%
0.01
32.93%
0.00
87.45%
0.00
43.11%
interest coverage
-16.88
-
-10.87
35.60%
-5.86
46.14%
-14.12
141.10%
-19.16
35.75%
-4.08K
-
-459.40
88.73%
-1.78K
286.65%
-67.14
96.22%
interest debt per share
371.39
-
388.00
4.47%
716.82
84.75%
476.87
33.47%
13.86
97.09%
0.31
97.78%
14.11
4,480.19%
37.75
167.61%
6.23
83.50%
3.85
38.24%
0.81
78.84%
inventory turnover
1.50
-
4.71
214.93%
3.03
35.58%
3.55
17.06%
1.24
65.20%
3.65
195.51%
0.49
86.49%
1.36
176.47%
1.96
44.03%
3.81
94.08%
1.69
55.79%
invested capital
-0.84
-
-7.68
812.01%
0.57
107.42%
1.13
98.56%
0.00
-
0.29
12,741.10%
0.34
16.08%
0.11
68.59%
0.10
9.48%
0.08
18.22%
market cap
238.86M
-
238.86M
0%
86.82M
63.65%
40.82M
52.99%
11.86M
70.95%
11.94M
0.68%
34.87M
192.05%
25.20M
27.74%
22.13M
12.16%
6.50M
70.64%
3.87M
40.41%
net current asset value
-22.27M
-
-8.08M
63.73%
18M
322.80%
17.85M
0.86%
6.48M
63.67%
11.67M
79.94%
4.19M
64.07%
12.90M
207.73%
22.67M
75.71%
17.38M
23.34%
7.97M
54.13%
net debt to ebitda
-1.15
-
0.14
112.28%
-0.06
145.80%
-1.29
1,881.54%
0.66
151.59%
0.52
20.94%
0.30
42.34%
0.23
25.53%
1.38
513.90%
0.82
40.70%
0.43
47.81%
net income per share
-322.62
-
-448.39
38.98%
-503.00
12.18%
-353.85
29.65%
-291.38
17.65%
-143.16
50.87%
-181.50
26.78%
-24.20
86.67%
-30.33
25.30%
-26.05
14.11%
-11.30
56.60%
operating cash flow per share
-238.26
-
-361.54
51.74%
-423.24
17.07%
-307.53
27.34%
-259.07
15.76%
-144.76
44.12%
-108.11
25.32%
-121.37
12.26%
-48.62
59.94%
-23.32
52.04%
-12.36
46.98%
payables turnover
3.06
-
8.18
167.54%
0.37
95.50%
4.03
995.11%
0.77
80.82%
0.25
67.68%
1.80
619.78%
1.27
29.59%
2.39
88.99%
3.40
42.14%
4.12
21.09%
receivables turnover
6.33
-
4.91
22.39%
6.87
39.93%
5.98
12.94%
3.26
45.50%
8.71
167.32%
1.94
77.72%
5.71
194.26%
4.95
13.39%
7.74
56.31%
10.37
34.05%
research and ddevelopement to revenue
1.30
-
1.43
10.53%
1.66
15.49%
2.72
64.09%
1.84
32.30%
4.15
125.32%
6.07
46.47%
0.99
83.68%
0.57
42.11%
0.15
73.58%
0.26
71.69%
return on tangible assets
-1.38
-
-0.74
46.72%
-0.24
67.18%
-0.35
43.42%
-0.95
173.28%
-0.56
40.81%
-0.89
57.97%
-0.13
85.40%
-0.37
187.07%
-0.54
45.52%
-0.71
31.52%
revenue per share
158.39
-
170.71
7.78%
151.66
11.16%
57.48
62.10%
74.69
29.92%
15.55
79.18%
7.35
52.74%
32.27
339.11%
12.74
60.51%
16.61
30.34%
4.31
74.06%
roe
0.76
-
9.73
1,175.34%
-0.45
104.59%
-0.88
98.04%
-1.96
121.90%
-1.05
46.38%
-3.75
256.24%
-0.22
94.20%
-0.52
138.74%
-0.74
43.05%
-1.09
46.68%
roic
4.03
-
-1.22
130.32%
-0.25
79.81%
-0.39
59.64%
-1.79
354.57%
-1.31
26.60%
-1.69
28.66%
-0.49
71.03%
-0.94
92.46%
-0.77
17.84%
-0.99
27.88%
sales general and administrative to revenue
1.23
-
1.45
17.92%
2.05
41.61%
3.84
87.10%
2.65
31.15%
7.93
199.61%
11.61
46.42%
2.05
82.34%
shareholders equity per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
48.44
64.41%
111.36
129.91%
58.44
47.52%
35.09
39.96%
10.38
70.42%
stock based compensation to revenue
0.20
-
0.14
29.14%
0.26
83.93%
0.33
29.20%
0.37
10.22%
1.06
189.18%
1.96
84.78%
0.25
87.01%
0.23
10.58%
0.11
51.12%
0.13
21.09%
tangible asset value
-17.30M
-
-1.89M
89.10%
40.23M
2,233.95%
22.20M
44.82%
8.01M
63.93%
12.81M
60.05%
8.33M
35.03%
27.77M
233.58%
30.71M
10.58%
20.86M
32.08%
12.66M
39.29%
tangible book value per share
-422.91
-
-46.09
89.10%
1.13K
2,544.92%
400.27
64.48%
148.54
62.89%
136.10
8.38%
52.34
61.54%
111.55
113.13%
57.73
48.25%
34.80
39.71%
10.24
70.58%
working capital
-4.98M
-
7.43M
249.21%
48.57M
554.01%
49.09M
1.08%
11.52M
76.53%
19.82M
72.04%
22.73M
14.68%
25.38M
11.66%
30.35M
19.57%
21.19M
30.18%
11.38M
46.28%

All numbers in USD (except ratios and percentages)